10 Small Cap Stocks with High Potential
As we transition from a tumultuous summer in the financial markets, characterized by rising expectations for interest rate cuts and the consequent impacts on stock and bond performances, investors are...
Arcutis Biotherapeutics Inc. (ARQT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 10,004,492 | $93,041,776 | +28% | 3.41% |
| 2. | Rubric Capital Management David Rosen | 9,816,672 | $91,295,050 | +31% | 2.39% |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 6,879,072 | $63,975,370 | -1% | 0.37% |
| 4. | Citadel Investment Group Ken Griffin | 2,932,647 | $27,273,617 | +54% | 0% |
| 5. | Cormorant Asset Management Bihua Chen | 2,525,000 | $23,482,500 | +19% | 1.35% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.50 | 21,052 | 8,785,284 | 2024-03-04 | Filing | ||
| $6.38 | 1,463 | Officer, Director | 515,145 | 2023-05-31 | Filing | |
| $2.50 | 80,000 | Large Shareholder | 8,764,232 | 2023-10-24 | Filing | |
| $20.00 | 250,000 | Large Shareholder | 8,684,232 | 2022-08-05 | Filing | |
| $25.00 | 296,000 | Large Shareholder, Director | 902,286 | 2020-10-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.26 | 10,000 | Director | 181,944 | 2024-10-01 | Filing | |
| $10.01 | 3,725 | Officer | 136,635 | 2024-10-02 | Filing | |
| $9.48 | 11,626 | Officer | 158,374 | 2024-09-24 | Filing | |
| $10.77 | 10,000 | Director | 191,944 | 2024-09-03 | Filing | |
| $8.29 | 1,728 | Officer | 194,859 | 2024-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,066,082 | $29,283,445 | 0.02% | |
| 2. | 8,764,232 | $28,308,469 | 1.51% | |
| 3. | 6,083,072 | $19,648,324 | 0% | |
| 4. | 5,916,546 | $19,110,443 | 0% | |
| 5. | 4,896,513 | $15,815,736 | 0% |
News See All
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q2 2024 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to Arcutis Biotherapeutics Q2 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript
Operator: Good day and welcome to Arcutis Biotherapeutics' 2024 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript
Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.65. Arcutis Biotherapeutics, Inc.
5 High Growth Micro-cap Stocks to Buy
3 Wall Street analysts covered Blade Air Mobility, Inc. (NASDAQ:BLDE) over the last three months, and all kept a Buy rating on the stock.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Arcutis Biotherapeutics Third Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
11 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at 11 cheap small cap stocks to buy before the next breakout.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
